Carlos H Miguel

Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial

Á. Avezum, R. Lopes, R. Rosa, 2022, The Lancet Regional Health - Americas.